Still some short-term pain for New Brunswick pharmacists but NBPA sees encouraging signs from the province P harmacists in New Brunswick continue to feel economic pressures due to the province's drug policies but there are signs the government is willing to address at least some of pharmacy's concerns in the future.
"We are still struggling immensely with the short-term impact of the policies, " says Paul Blanchard, executive director of the New Brunswick Pharmacists' Association (NBPA). "But we think we are building a process and a framework for the longer term. "
Like all provinces, New Brunswick has taken steps to curtail drug expenditures through price reductions on generics. Through a series of reductions that began in June of 2012, generic drug prices in the province have dropped from 50% to 70% of brand-name prices to 25%, and in some cases, 18%. According to Mr. Blanchard, little has been done to help pharmacy adjust to the steep declines in revenue.
"Many of the provinces have implemented change in a more measured way but we've had 4 cuts in a 12-month period with minimal reinvestment, " he says. "A year ago we had a $1 fee increase but that pales in comparison to some of the transitional supports provided to pharmacists in other provinces. "
The province is achieving more drug savings than originally budgeted and yet the pace of reinvestment in pharmacy services has been "alarmingly slow, " Mr. Blanchard says.
The association was also frustrated by many of the regulatory amendments the province proposed in May 2013, including reductions to dispensing fees for methadone and for more expensive brand-name drugs. For example, explains the executive director, a drug costing $1500 currently has a fee of $63 but the proposed regulations propose would lower that fee to $10.50. "We've never had any discussion or consultation about brand pricing; yet, here we have the government suddenly regulating changes in this area, " he adds.
Positive developments for pharmacists
The NBPA has long been calling for the government to sit down and negotiate a formal agreement with pharmacists-something that hasn't existed since 1996. There have been some promising developments, says Mr. Blanchard.
"We've been assured we will be beginning discussions around an agreement process very soon. We're working on the skeleton around that; we're not yet talking about plugging in the numbers because that would be negotiating."
The association is also pleased that it has been able to reach agreement with the province on the terms of reference and guiding principles of a joint working group to address broader issues related to professional services and pharmacy's role in the health care system. "One of the good hallmarks of this working group is the principle of sustainability. It's important that the prescription drug program remains sustainable but it's also important that community pharmacy is sustainable, " he says. "The health department is signing off on that principle and that's very important. "
The association has some optimism that a new pharmacy agreement will be in place by late 2013 or early 2014, says Mr. Blanchard. The NBPA is also expecting that new pharmacy legislation to authorize pharmacist prescribing for a number of minor ailments will be introduced in the New Brunswick legislature by the fall of 2013.
